New training aims to ease burden on caregivers of schizophrenia patients

NCT ID NCT05036590

First seen Jun 13, 2026 · Last updated Jun 22, 2026 · Updated 1 time

Summary

This study tests whether training mental health professionals to deliver a short psychoeducational program (BREF) can reduce the burden on caregivers of people with schizophrenia or first psychotic episode. The trial will include 206 caregivers, comparing those who receive the program to those who do not. The goal is to see if this training helps caregivers feel less stressed and better able to cope.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hopital Vinatier

    RECRUITING

    Bron, 69678, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

psychoeducational program (BREF)

What this could lead to

If successful, this could provide a practical way to train professionals to support caregivers, reducing their stress and improving patient outcomes.

What could go wrong

This is a non-randomized study with a control period, so results may be influenced by other factors. The program's effectiveness depends on implementation quality.

Conditions

The condition(s) this trial relates to.

Schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.